📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer. (2017)

First Author: Zanini E

Attributed to: Identification, roles and mechanisms of long non-coding RNAs in stem cells and metastasis in breast cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-17-0081

PubMed Identifier: 28775148

Publication URI: http://europepmc.org/abstract/MED/28775148

Type: Journal Article/Review

Volume: 16

Parent Publication: Molecular cancer therapeutics

Issue: 10

ISSN: 1535-7163